side effects include:
nausea
vaginitis
redness at injection site
diarrhea
headache
dizziness
gatifloxacin
active ingredient
tequin
most adverse events
gatifloxacin
adverse reactions
treated patients
gastrointestinal side effects
nausea
diarrhea
other gastrointestinal effects
patients
abdominal pain
anorexia
constipation
dyspepsia
flatulence
gastritis
glossitis
mouth ulcer
oral moniliasis
stomatitis
vomiting
additional side effects
patients
colitis
dysphagia
gastrointestinal hemorrhage
gingivitis
halitosis
hematemesis
pseudomembranous colitis
rectal hemorrhage
pancreatitis
taste loss
quinolone class antibiotics
intestinal perforation
onset of pseudomembranous colitis symptoms
antimicrobial treatment
increased duration therapy
risk of clostridium
difficile-associated diarrhea
cdad
long-term care facility
patients
cdad after an average
day duration of gatifloxacin therapy
contrast
mean duration of therapy
days in patients
cdad
facility
formulary change from levofloxacin
gatifloxacin
higher rate of cdad
levofloxacin
rate
formulary
levofloxacin
nervous system
side effects
dizziness
headache
insomnia
nervousness
paresthesia
somnolence
tremor
vasodilatation
vertigo
patients
additional nervous system
side effects
patients
asthenia
ataxia
convulsion
hyperesthesia
migraine
seizures
peripheral neuropathy
quinolone class antibiotics
possible exacerbation of myasthenia gravis
dysphasia
generalized seizures
myoclonus
year-old woman after a dose of intravenous gatifloxacin
dermatologic side effects
dry skin
rash
pruritus
sweating
patients
reported side effects
maculopapular rash
vesiculobullous rash
hypersensitivity side effects
allergic reactions
anaphylactic reactions
stevens-johnson syndrome
angioneurotic edema
quinolone class antibiotics
anaphylactoid reactions
shock
purpura
serum sickness
erythema multiforme
erythema nodosum
exfoliative dermatitis
toxic epidermal necrolysis
photosensitivity
vesiculobullous eruption
metabolic side effects
patients
peripheral edema
thirst
severe hyperglycemia
hyperosmolar nonketotic hyperglycemia
severe hypoglycemia
hypoglycemia coma
serum amylase
electrolyte abnormalities
quinolone class antibiotics
acidosis
elevations in serum triglycerides
serum cholesterol
serum potassium
gatifloxacin
active ingredient
tequin
cases
fda
cases
ventricular fibrillation
including fatalities
cardiovascular
side effects
palpitation
hypertension
patients
bradycardia
cyanosis
edema
substernal chest pain
tachycardia
patients
prolongation of the qtc interval
syncope
hypotension
endocrine side effects
diabetes mellitus
blood glucose disturbances
cases
elderly patients
greater risk
developing hyperglycemia
hypoglycemia
patients with type
diabetes
serum insulin
serum glucose
hypoglycemia
cases
patients
oral hypoglycemic agents
days
initiating gatifloxacin therapy
elderly patients
severe hypoglycemia
intravenous dextrose until the gatifloxacin
hyperglycemia
including
nonketotic hyperglycemic coma
diabetic patients
undiagnosed diabetics
days
initiating therapy
severe hypoglycemia
hyperglycemia
nondiabetic patients
days of therapy
fatal hyperglycemia
elderly nondiabetic patients
cases of severe hyperglycemia
us food
drug administration
age range
years
patients
history of diabetes
cases of hypoglycemia
cases of hyperglycemia
canada
hyperglycemia
high drug exposure in patients with age-associated renal dysfunction
hyperglycemia
blood glucose mg/l
year-old woman after days of gatifloxacin mg/day
serum creatinine upon initiation of therapy
mg/dl
genitourinary side effects
vaginitis
breast pain
dysuria
hematuria
metrorrhagia
quinolone class antibiotics
albuminuria
candiduria
crystalluria
cylindruria
hematuria
vaginal candidiasis
local injection site reactions
patients
receiving intravenous gatifloxacin
active ingredient
tequin
hematologic side effects
patients
ecchymosis
epistaxis
neutropenia
increased inr/prothrombin time
thrombocytopenia
quinolone class antibiotics
agranulocytosis
ocular side effects
abnormal vision
eye pain
patients
ptosis
eye photosensitivity
photophobia
patients
quinolone class antibiotics
nystagmus
cataracts
multiple punctate
lenticular opacities
nonspecific side effects
pain
chest pain
chills
edema
fever
patients
other side effects
patients
alcohol intolerance
cheilitis
generalized edema
lymphadenopathy
mouth edema
tongue edema
false positive results on urine drug screens for opiates
tinnitus
taste perversion
patients
ear pain
parosmia
distortion of odor quality
patients
respiratory side effects
patients
dyspnea
pharyngitis
other respiratory side effects
patients
asthma
bronchospasm
hyperventilation
hemoptysis
quinolone class antibiotics
hiccough
musculoskeletal side effects
arthralgia
leg
patients
arthritis
bone pain
hypertonia
myalgia
myasthenia
neck pain
patients
tendon rupture
psychiatric side effects
abnormal dreams
agitation
anxiety
confusion
patients
abnormal thinking
depersonalization
depression
euphoria
hallucination
hostility
panic attack
paranoia
psychosis
stress
quinolone class antibiotics
manic reactions
year-old male developed symptoms of hepatocellular necrosis
including jaundice
elevated alt
ast
inr
aptt
ammonia concentrations
day course of oral gatifloxacin
active ingredient
tequin
liver biopsy
micronodular cirrhosis with intranodular hepatocellular necrosis
multiple organ failure days
year-old woman
signs of hepatitis
taking
taking oral gatifloxacin for days
including nausea
lethargy
abdominal pain
jaundice
icterus
eosinophilia
elevated liver function tests
including bilirubin
mg/dl
liver biopsy
acute hepatitis with eosinophilic infiltrates
hepatic side effects
increased alt
ast
alkaline phosphatase
bilirubin in less
patients
hepatitis
cholestasis with concomitant pancreatitis
fulminant hepatic failure
quinolone class antibiotics
hepatic necrosis
renal side effects
abnormal renal function
including
acute renal failure
quinolone class antibiotics
renal calculi
side effects of tequin
fda
healthcare professional for medical advice